CoChat

Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis

Open access
Snoek, Susanne A, Verstege, Marleen I, van der Zanden, Esmerij P, Deeks, Nigel, Bulmer, David C, Skynner, Michael, Lee, Kevin, te Velde, Anje A, Boeckxstaens, Guy E, de Jonge, Wouter J · 2010 · British Journal of Pharmacology
Cited by 82

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background and purpose: In various models vagus nerve activation has been shown to ameliorate intestinal inflammation, via nicotinic acetylcholine receptors (nAChRs) expressed on immune cells. As the α7 nAChR has been put forward to mediate this effect, we studied the effect of nicotine and two selective α7 nAChR agonists (AR‐R17779, (‐)‐spiro[1‐azabicyclo[2.2.2] octane‐3,5′‐oxazolidin‐2′‐one and GSK1345038A) on disease severity in two mouse models of experimental colitis. Experimental approach: Colitis was induced by administration of 1.5% dextran sodium sulphate (DSS) in drinking water or 2 mg 2,4,6‐trinitrobenzene sulphonic acid (TNBS) intrarectally. Nicotine (0.25 and 2.50 µmol·kg−1), AR‐R17779 (0.6–30 µmol·kg−1) or GSK1345038A (6–120 µmol·kg−1) was administered daily by i.p. injection. After 7 (DSS) or 5 (TNBS) days clinical parameters and colonic inflammation were scored. Key results: Nicotine and both α7 nAChR agonists reduced the activation of NF‐κB and pro‐inflammatory cytokines in whole blood and macrophage cultures. In DSS colitis, nicotine treatment reduced colonic cytokine production, but failed to reduce disease parameters. Reciprocally, treatment with AR‐R17779 or GSK1345038A worsened disease and led to increased colonic pro‐inflammatory cytokine levels in DSS colitis. The highest doses of GSK1345038A (120 µmol·kg−1) and AR‐R17779 (30 µmol·kg−1) ameliorated clinical parameters, without affecting colonic inflammation. Neither agonist ameliorated TNBS‐induced colitis. Conclusions and implications: Although nicotine reduced cytokine responses in vitro, both selective α7 nAChR agonists worsened the effects of DSS‐induced colitis or were ineffective in those of TNBS‐induced colitis. Our data indicate the need for caution in evaluating α7 nAChR as a drug target in colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.00699.x

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 82

Metadata

Authors
Snoek, S. A., Verstege, M. I., van der Zanden, E. P., Deeks, N., Bulmer, D. C., Skynner, M., Lee, K., te Velde, A. A., Boeckxstaens, G. E., & de Jonge, W. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2010-04-26
Volume
160
Issue
2
Pages
322-333
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2158445295
Cited by
82
References
12
FWCI
3.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00699.x
The paper
Snoek, S. A., Verstege, M. I., van der Zanden, E. P., Deeks, N., Bulmer, D. C., Skynner, M., Lee, K., te Velde, A. A., Boeckxstaens, G. E., & de Jonge, W. J. (2010). Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00699.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.